🇺🇸 FDA
Patent

US 10500261

Synthetic antigen constructs against campylobacter jejuni

granted A61KA61K2039/545A61K39/105

Quick answer

US patent 10500261 (Synthetic antigen constructs against campylobacter jejuni) held by United States of America as represented by the Secretary of the Air Force expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K2039/545, A61K39/105, A61K39/385, A61P